参考文献
(在框内滑动手指即可浏览)
[1] Bahadoer RR,Dijkstra EA,van Etten B,et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy,TME,and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised,open-label,phase 3 trial[J]. Lancet Oncol,2021,22(1):29-42.
[2] Conroy T,Bosset JF,Etienne PL,et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre,randomised,open-label,phase 3 trial[J]. Lancet Oncol,2021,22(5):702-715.
[3] Hong YS,Kim SY,Lee JS,et al. Oxaliplatin-based adjuvant chemotherapy for rectal cancer after preoperative chemoradiotherapy (ADORE): long-term results of a randomized controlled trial[J]. J Clin Oncol,2019,37(33):3111-3123.
[4] Jin J,Tang Y,Hu C,et al. Multicenter,randomized,phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR)[J]. J Clin Oncol,2022,40(15):1681-1692.
[5] van der Valk M,Hilling DE,Bastiaannet E,et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study[J]. Lancet,2018,391(10139):2537-2545.
[6] Maas M,Nelemans PJ,Valentini V,et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data[J]. Lancet Oncol,2010,11(9):835-844.
[7] Fan WH,Xiao J,An X,et al. Patterns of recurrence in patients achieving pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer[J]. J Cancer Res Clin Oncol,2017,143(8):1461-1467.
[8] Petrelli F,Trevisan F,Cabiddu M,et al. Total neoadjuvant therapy in rectal cancer: a systematic review and meta-analysis of treatment outcomes[J]. Ann Surg,2020,271(3):440-448.
[9] Kasi A,Abbasi S,Handa S,et al. Total neoadjuvant therapy vs standard therapy in locally advanced rectal cancer: a systematic review and meta-analysis[J]. JAMA Netw Open,2020,3(12):e2030097.
[10] Morton D,Seymour M,Magill L,et al. Preoperative chemotherapy for operable colon cancer: mature results of an international randomized controlled trial[J]. J Clin Oncol,2023,41(8):1541-1552.
[11] Sclafani F,Corrò C,Koessler T. Debating pros and cons of total neoadjuvant therapy in rectal cancer[J]. Cancers (Basel),2021,13(24): 6361
[12] Keller DS,Berho M,Perez RO,et al. The multidisciplinary management of rectal cancer[J]. Nat Rev Gastroenterol Hepatol,2020,17(7):414-429.
[13] Garcia-Aguilar J,Chow OS,Smith DD,et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre,phase 2 trial[J]. Lancet Oncol,2015,16(8):957-966.
[14] Cui J,Dou X,Sun Y,et al. Consolidation chemotherapy may improve pathological complete response for locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a retrospective study[J]. PeerJ,2020,8:e9513.
[15] Ominelli J,Valadão M,Araujo R,et al. The evolving field of neoadjuvant therapy in locally-advanced rectal cancer: evidence and prospects[J]. Clin Colorectal Cancer,2021,20(4):288-298.
[16] Cercek A,Roxburgh C,Strombom P,et al. Adoption of total neoadjuvant therapy for locally advanced rectal cancer[J]. JAMA Oncol,2018,4(6):e180071.
[17] Kim JK,Marco MR,Roxburgh C,et al. Survival after induction chemotherapy and chemoradiation versus chemoradiation and adjuvant chemotherapy for locally advanced rectal cancer[J]. Oncologist,2022,27(5):380-388.
[18] Chotard G,Capdepont M,Denost Q,et al. Effects of neoadjuvant chemotherapy plus chemoradiotherapy on lymph nodes in rectal adenocarcinoma[J]. Virchows Arch,2021,479(4):657-666.
[19] Ozer L,Yildiz I,Bayoglu V,et al. Tailored total neoadjuvant therapy for locally advanced rectal cancer: one size may not fit for all![J]. Colorectal Dis,2021,23(7):1662-1669.
[20] Fokas E,Allgäuer M,Polat B,et al. Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12[J]. J Clin Oncol,2019,37(34):3212-3222.
[21] Kim SY,Joo J,Kim TW,et al. A randomized phase 2 trial of consolidation chemotherapy after preoperative chemoradiation therapy versus chemoradiation therapy alone for locally advanced rectal cancer: KCSG CO 14-03[J]. Int J Radiat Oncol Biol Phys,2018,101(4):889-899.
[22] 李干斌,韩加刚,王振军,等. 新辅助放化疗治疗局部进展期直肠癌疗效分析[J]. 中国实用外科杂志,2021,41(2):184-189.
[23] Marco MR,Zhou L,Patil S,et al. Consolidation mFOLFOX6 chemotherapy after chemoradiotherapy improves survival in patients with locally advanced rectal cancer: final results of a multicenter phase II trial[J]. Dis Colon Rectum,2018,61(10):1146-1155.
[24] Cameron MG,Kersten C,Vistad I,et al. Palliative pelvic radiotherapy of symptomatic incurable rectal cancer - a systematic review[J]. Acta Oncol,2014,53(2):164-173.
[25] Sapienza LG,Ning MS,Jhingran A,et al. Short-course palliative radiation therapy leads to excellent bleeding control: A single centre retrospective study[J]. Clin Transl Radiat Oncol,2019,14:40-46.
[26] Markovina S,Youssef F,Roy A,et al. Improved metastasis- and disease-free survival with preoperative sequential short-course radiation therapy and FOLFOX chemotherapy for rectal cancer compared with neoadjuvant long-course chemoradiotherapy: results of a matched pair analysis[J]. Int J Radiat Oncol Biol Phys,2017,99(2):417-426.
[27] van der Valk M,Marijnen C,van Etten B,et al. Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - results of the international randomized RAPIDO-trial[J]. Radiother Oncol,2020,147:75-83.
[28] Wu H,Fan C,Fang C,et al. Preoperative short-course radiotherapy followed by consolidation chemotherapy for treatment with locally advanced rectal cancer: a meta-analysis[J]. Radiat Oncol,2022,17(1):14.
[29] Fokas E,Schlenska-Lange A,Polat B,et al. Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO/AIO-12 randomized clinical trial[J]. JAMA Oncol,2022,8(1):e215445.
[30] Erlandsson J,Holm T,Pettersson D,et al. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre,randomised,non-blinded,phase 3,non-inferiority trial[J]. Lancet Oncol,2017,18(3):336-346.
[31] Garcia-Aguilar J,Patil S,Gollub MJ,et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy[J]. J Clin Oncol,2022,40(23):2546-2556.
[32] Yigit B,Kabul Gurbulak E,Ton Eryilmaz O. Usefulness of endoscopic tattooing before neoadjuvant therapy in patients with clinical complete response in locally advanced rectal cancer for providing a safe distal surgical margin[J]. J Laparoendosc Adv Surg Tech A,2022,32(5):506-514.